drugset / Trial / NCT01017263

Vyvanse and Glucose Intolerance in Children With Attention Deficit Hyperactivity Disorder (ADHD) and Obesity

NCT01017263 ↗

Phase 4 Terminated 14 enrolled Duke University Shire · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study to assess the effects of chronic administration of Vyvanse (lis-dexamphetamine) on glucose metabolism in a sample of children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD) who also have glucose intolerance and are obese.

Timeline

Start
2009-12
Primary completion
2012-08
Completion
2012-08

Outcome

Outcome not reported

Stopped: “Due very high screen fail rate, pre study feasibility not consistent with screened population.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lisdexamfetamine Other / unclassified 70 mg —